Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Immunology Research"
DOI: 10.1158/2326-6066.cir-20-0317
Abstract: Arginine deprivation is commonly thought to be immunosuppressive. However, this study demonstrates that this is not always the case. Here, arginine deprivation in combination with different immunotherapies can enhance antitumor responses elicited by these immunotherapies.… read more here.
Keywords: arginase; combination; tumor; agonist anti ... See more keywords